Emory University as of Sept. 30, 2019
Portfolio Holdings for Emory University
Emory University holds 19 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Berkshire Hathaway (BRK.A) | 61.5 | $31M | 100.00 | 311830.00 | |
| Eidos Therapeutics | 4.8 | $2.4M | 68k | 35.97 | |
| Synthorx | 4.7 | $2.4M | 145k | 16.27 | |
| Wave Life Sciences (WVE) | 3.2 | $1.6M | 78k | 20.53 | |
| Rhythm Pharmaceuticals (RYTM) | 3.1 | $1.6M | 72k | 21.58 | |
| Ra Pharmaceuticals | 2.8 | $1.4M | 60k | 23.66 | |
| BioCryst Pharmaceuticals (BCRX) | 2.7 | $1.4M | 480k | 2.87 | |
| Meiragtx Holdings (MGTX) | 2.5 | $1.3M | 81k | 15.95 | |
| Orchard Therapeutics Plc ads | 2.5 | $1.3M | 109k | 11.88 | |
| Zogenix | 2.0 | $997k | 25k | 40.06 | |
| Arcosa (ACA) | 1.9 | $955k | 28k | 34.20 | |
| Heron Therapeutics (HRTX) | 1.8 | $925k | 50k | 18.51 | |
| Retrophin | 1.8 | $895k | 77k | 11.60 | |
| Myovant Sciences | 1.5 | $762k | 147k | 5.20 | |
| Genomic Health | 1.3 | $645k | 9.5k | 67.85 | |
| Summit Midstream Partners | 0.7 | $342k | 71k | 4.85 | |
| Cocrystal Pharma Inc Com Par | 0.6 | $312k | 153k | 2.04 | |
| Spdr S&p 500 Etf (SPY) | 0.6 | $280k | 942.00 | 297.24 | |
| Inflarx Nv (IFRX) | 0.2 | $91k | 37k | 2.47 |
